Healios KK (FRA:6VX) FCF Margin % : 0.00% (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Healios KK FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Healios KK's Free Cash Flow for the three months ended in Dec. 2024 was €0.00 Mil. Healios KK's Revenue for the three months ended in Dec. 2024 was €0.00 Mil. Therefore, Healios KK's FCF Margin % for the quarter that ended in Dec. 2024 was 0.00%.

As of today, Healios KK's current FCF Yield % is -9.66%.

The historical rank and industry rank for Healios KK's FCF Margin % or its related term are showing as below:

FRA:6VX' s FCF Margin % Range Over the Past 10 Years
Min: -15770.37 Med: -5403.33 Max: -233.7
Current: -615.16

During the past 11 years, the highest FCF Margin % of Healios KK was -233.70%. The lowest was -15770.37%. And the median was -5403.33%.

FRA:6VX's FCF Margin % is ranked worse than
71.97% of 999 companies
in the Biotechnology industry
Industry Median: -121.51 vs FRA:6VX: -615.16

Healios KK FCF Margin % Historical Data

The historical data trend for Healios KK's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Healios KK FCF Margin % Chart

Healios KK Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

FCF Margin %

Get a 7-Day Free Trial

-15,757.48

-13,133.86

-5,400.95

-2,354.22

-379.26

Healios KK Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Dec24
FCF Margin %	Get a 7-Day Free Trial															-8,340.91	-15,313.33	-6,242.62	-156.40	-

Competitive Comparison of Healios KK's FCF Margin %

For the Biotechnology subindustry, Healios KK's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Healios KK's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Healios KK's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Healios KK's FCF Margin % falls into.

Save Embed

;

Save Embed

;

Healios KK FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Healios KK's FCF Margin for the fiscal year that ended in Dec. 2024 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2024 )	/	Revenue (A: Dec. 2024 )
	=	-13.187	/	3.477
	=	-379.26 %

Healios KK's FCF Margin for the quarter that ended in Dec. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2024 )	/	Revenue (Q: Dec. 2024 )
	=	0	/	0
	=	%

Healios KK FCF Margin % Related Terms

Thank you for viewing the detailed overview of Healios KK's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Healios KK Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Healios KK (FRA:6VX) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

HLOSF:USA 4593:Japan

Address

World Trade Center Bldg. 15th Floor, 2-4-1 Hamamatsucho, Minato-ku, Tokyo, JPN, 105-6115

Website

https://www.healios.co.jp

Healios KK is involved in development and sales of opthalmological surgery adjuvants and research, development and manufacture of cell therapy products and regenerative medicine products. The company is developing treatments for age-related macular degeneration and organ anlage transplantation therapy.

Healios KK Headlines

No Headlines